An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects
NCT01765855
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class
Conditions
Health Volunteers
Interventions
DRUG:
Betrixaban single oral dose
Sponsor
Portola Pharmaceuticals